The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Eckhardt Juergen | Director | Grant(A) | 21K | — | $0 |
| Jun 9, 2026 | Bjerkholt Eric | Director | Grant(A) | 21K | — | $0 |
| Jun 9, 2026 | Dere Willard H | Director | Grant(A) | 21K | — | $0 |
| Jun 9, 2026 | Reid Laurence | Director | Grant(A) | 17K | — | $0 |
| Jun 5, 2026 | Wapnick Pamela | Chief Financial Officer | Sell(S) | 3K | $1.30 | $4K |
| Jun 5, 2026 | Irish Jian | See Remarks, Director | Sell(S) | 4K | $1.30 | $5K |
| Jun 5, 2026 | Wein Matthew | See Remarks | Sell(S) | 558 | $1.30 | $725 |
| Mar 5, 2026 | Irish Jian | Chief Executive Officer, Director | Sell(S) | 2K | $1.60 | $3K |
| Mar 5, 2026 | Wein Matthew | See Remarks | Sell(S) | 482 | $1.60 | $771 |
| Mar 5, 2026 | Wapnick Pamela | Chief Financial Officer | Sell(S) | 2K | $1.60 | $3K |
| Dec 5, 2025 | Irish Jian | Chief Executive Officer, Director | Gift(G) | 228K | — | $0 |
| Dec 5, 2025 | Irish Jian | Chief Executive Officer, Director | Sell(S) | 2K | $1.77 | $3K |
| Dec 5, 2025 | Wapnick Pamela | Chief Financial Officer | Sell(S) | 2K | $1.77 | $3K |
| Dec 5, 2025 | Wein Matthew | See Remarks | Sell(S) | 199 | $1.77 | $352 |
| Dec 5, 2025 | Thomas Brian C. | Director | Sell(S) | 4K | $1.77 | $7K |
| Dec 1, 2025 | Wein Matthew | See Remarks | Grant(A) | 96K | $1.60 | $154K |
| Dec 1, 2025 | Irish Jian | Chief Executive Officer, Director | Grant(A) | 38K | $1.60 | $60K |
| Dec 1, 2025 | Irish Jian | Chief Executive Officer, Director | Grant(A) | 211K | $1.60 | $338K |
| Dec 1, 2025 | Irish Jian | Chief Executive Officer, Director | Grant(A) | 225K | — | $0 |
| Dec 1, 2025 | Wapnick Pamela | Chief Financial Officer | Grant(A) | 120K | $1.60 | $192K |
| Sep 5, 2025 | Wein Matthew | See Remarks | Sell(S) | 199 | $1.81 | $360 |
| Sep 5, 2025 | Irish Jian | Chief Executive Officer, Director | Sell(S) | 2K | $1.81 | $3K |
| Sep 5, 2025 | Wapnick Pamela | Chief Financial Officer | Sell(S) | 2K | $1.81 | $3K |
| Sep 5, 2025 | Thomas Brian C. | Director | Sell(S) | 3K | $1.81 | $5K |
| Sep 2, 2025 | Reid Laurence | Director | Grant(A) | 42K | — | $0 |
| Jun 10, 2025 | Bjerkholt Eric | Director | Grant(A) | 9K | — | $0 |
| Jun 10, 2025 | Dere Willard H | Director | Grant(A) | 21K | — | $0 |
| Jun 10, 2025 | Eckhardt Juergen | Director | Grant(A) | 21K | — | $0 |
| Jun 6, 2025 | Irish Jian | See Remarks, Director | Sell(S) | 6K | $1.75 | $11K |
| Jun 6, 2025 | Thomas Brian C. | Chief Executive Officer, Director | Sell(S) | 11K | $1.75 | $19K |
| Jun 6, 2025 | Wapnick Pamela | Chief Financial Officer | Sell(S) | 2K | $1.75 | $3K |
| Jun 6, 2025 | Noonberg Sarah B. | Chief Medical Officer | Sell(S) | 5K | $1.75 | $9K |
| Jun 6, 2025 | Wein Matthew | See Remarks | Sell(S) | 199 | $1.75 | $348 |
| Apr 1, 2025 | Noonberg Sarah B. | Chief Medical Officer | Grant(A) | 14K | — | $0 |
| Apr 1, 2025 | Noonberg Sarah B. | Chief Medical Officer | Grant(A) | 84K | — | $0 |
| Apr 1, 2025 | Wein Matthew | See Remarks | Grant(A) | 4K | — | $0 |
| Apr 1, 2025 | Wein Matthew | See Remarks | Grant(A) | 4K | — | $0 |
| Apr 1, 2025 | Wein Matthew | See Remarks | Grant(A) | 22K | — | $0 |
| Apr 1, 2025 | Wein Matthew | See Remarks | Grant(A) | 23K | — | $0 |
| Apr 1, 2025 | Irish Jian | See Remarks, Director | Grant(A) | 23K | — | $0 |
| Apr 1, 2025 | Irish Jian | See Remarks, Director | Grant(A) | 140K | — | $0 |
| Apr 1, 2025 | Thomas Brian C. | Chief Executive Officer, Director | Grant(A) | 32K | — | $0 |
| Apr 1, 2025 | Thomas Brian C. | Chief Executive Officer, Director | Grant(A) | 196K | — | $0 |
| Apr 1, 2025 | Wapnick Pamela | Chief Financial Officer | Grant(A) | 14K | — | $0 |
| Apr 1, 2025 | Wapnick Pamela | Chief Financial Officer | Grant(A) | 84K | — | $0 |
| Mar 5, 2025 | Wapnick Pamela | Chief Financial Officer | Sell(S) | 2K | $1.87 | $3K |
| Mar 5, 2025 | Wein Matthew | See Remarks | Sell(S) | 930 | $1.87 | $2K |
| Feb 3, 2025 | Bjerkholt Eric | Director | Grant(A) | 42K | — | $0 |
| Dec 5, 2024 | Wapnick Pamela | Chief Financial Officer | Sell(S) | 2K | $1.86 | $3K |
| Sep 5, 2024 | Wapnick Pamela | Chief Financial Officer | Sell(S) | 6K | $2.88 | $18K |
| Apr 1, 2024 | Thomas Brian C. | Chief Executive Officer, Director | Grant(A) | 119K | — | $0 |
| Apr 1, 2024 | Thomas Brian C. | Chief Executive Officer, Director | Grant(A) | 500K | — | $0 |
| Apr 1, 2024 | Dere Willard H | Director | Grant(A) | 79K | — | $0 |
| Apr 1, 2024 | Delaney Simren | See Remarks | Grant(A) | 7K | — | $0 |
| Apr 1, 2024 | Delaney Simren | See Remarks | Grant(A) | 29K | — | $0 |
| Apr 1, 2024 | Harnest Simon | See Remarks | Grant(A) | 12K | — | $0 |
| Apr 1, 2024 | Harnest Simon | See Remarks | Grant(A) | 49K | — | $0 |
| Apr 1, 2024 | Bernales Sebastian | Director | Grant(A) | 79K | — | $0 |
| Apr 1, 2024 | Noonberg Sarah B. | Chief Medical Officer | Grant(A) | 58K | — | $0 |
| Apr 1, 2024 | Noonberg Sarah B. | Chief Medical Officer | Grant(A) | 243K | — | $0 |
| Apr 1, 2024 | Wapnick Pamela | Chief Financial Officer | Grant(A) | 69K | — | $0 |
| Apr 1, 2024 | Wapnick Pamela | Chief Financial Officer | Grant(A) | 291K | — | $0 |
| Apr 1, 2024 | Wein Matthew | See Remarks | Grant(A) | 10K | — | $0 |
| Apr 1, 2024 | Wein Matthew | See Remarks | Grant(A) | 44K | — | $0 |
| Apr 1, 2024 | Borges Luis | Chief Scientific Officer | Grant(A) | 69K | — | $0 |
| Apr 1, 2024 | Borges Luis | Chief Scientific Officer | Grant(A) | 291K | — | $0 |
| Apr 1, 2024 | Eckhardt Juergen | Director | Grant(A) | 79K | — | $0 |
| Apr 1, 2024 | Irish Jian | See Remarks, Director | Grant(A) | 70K | — | $0 |
| Apr 1, 2024 | Irish Jian | See Remarks, Director | Grant(A) | 296K | — | $0 |
| Feb 13, 2024 | Bernales Sebastian | Director | Conversion(C) | 513K | — | — |
| Feb 13, 2024 | Bernales Sebastian | Director | Conversion(C) | 1.9M | — | — |
| Feb 13, 2024 | Bernales Sebastian | Director | Conversion(C) | 120K | — | $0 |
| Feb 13, 2024 | Bernales Sebastian | Director | Conversion(C) | 423K | — | $0 |
| Feb 13, 2024 | Bernales Sebastian | Director | Conversion(C) | 2.1M | — | $0 |
| Feb 13, 2024 | Bernales Sebastian | Director | Conversion(C) | 1.1M | — | $0 |
| Feb 13, 2024 | Bernales Sebastian | Director | Conversion(C) | 107K | — | $0 |
| Feb 13, 2024 | Bernales Sebastian | Director | Conversion(C) | 353K | — | $0 |
| Feb 13, 2024 | Novo Holdings A/S | 10% Owner | Buy(P) | 800K | $15.00 | $12.0M |
| Feb 13, 2024 | Novo Holdings A/S | 10% Owner | Conversion(C) | 839K | — | — |
| Feb 13, 2024 | Novo Holdings A/S | 10% Owner | Conversion(C) | 147K | — | — |
| Feb 13, 2024 | Novo Holdings A/S | 10% Owner | Conversion(C) | 692K | — | — |
| Feb 13, 2024 | Bayer World Investments B.V. | 10% Owner | Conversion(C) | 590K | — | — |
| Feb 13, 2024 | Bayer World Investments B.V. | 10% Owner | Conversion(C) | 1.2M | — | — |
| Feb 13, 2024 | Bayer World Investments B.V. | 10% Owner | Conversion(C) | 1.8M | — | — |
| Feb 13, 2024 | Bayer World Investments B.V. | 10% Owner | Conversion(C) | 510K | — | — |
| Feb 13, 2024 | Bayer World Investments B.V. | 10% Owner | Conversion(C) | 3.1M | — | $0 |
| Feb 13, 2024 | Bayer World Investments B.V. | 10% Owner | Conversion(C) | 891K | — | $0 |
| Feb 13, 2024 | Bayer World Investments B.V. | 10% Owner | Conversion(C) | 1.0M | — | $0 |
| Feb 13, 2024 | Bayer World Investments B.V. | 10% Owner | Conversion(C) | 2.1M | — | $0 |
| Feb 9, 2024 | Novo Holdings A/S | 10% Owner | Buy(P) | 100K | $10.25 | $1.0M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).